Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
455.5M
Cash
217.1M
Avg Qtr Burn
-17.82M
Short % of Float
20.25%
Insider Ownership
2.82%
Institutional Own.
90.50%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LNZ100 Details Presbyopia, Eye disease | NDA Acceptance for review |